ProAssurance’s $25 cash buyout converted a structurally challenged standalone insurer into a value-maximizing exit for shareholders.
Overview
ProAssurance was a specialty P&C insurer focused on medical professional liability, workers’ compensation, and related professional risks. Its standalone public-market story ended on June 26, 2026, when The Doctors Company acquired it for $25.00 per share in cash, valuing the deal at roughly $1.3 billion. The acquisition delisted ProAssurance from the NYSE and transformed it into a wholly owned subsidiary. Shareholders received a premium exit from a well-capitalized but structurally pressured insurer facing persistent underwriting losses and scale disadvantages.